Patent ID: 11944703
Assignee: CLEARSIDE BIOMEDICAL, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 15:
16. A method of administering a drug formulation to an eye via an ocular injector, the ocular injector including a puncture member defining a lumen with a longitudinal axis and a flexible cannula movably disposed in the lumen, the flexible cannula having an atraumatic distal tip, the method comprising:
inserting a distal end portion of the puncture member into the eye until the distal end portion of the puncture member reaches a suprachoroidal space (SCS);
advancing the flexible cannula distally through the lumen of the puncture member such that the atraumatic distal tip of the flexible cannula exits the lumen along the longitudinal axis, thereby expanding the SCS; and
administering the drug formulation to the expanded SCS such that the drug formulation is advanced posteriorly in the SCS.